4.7 Article

Takayasu Arteritis JACC Focus Seminar 3/4

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 81, Issue 2, Pages 172-186

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2022.09.051

Keywords

antirheumatic agents; endovascular procedures; immunosuppression; invasive procedures; vasculitis

Ask authors/readers for more resources

Takayasu arteritis is a rare inflammatory disease that primarily affects young women. Early diagnosis and prompt treatment are crucial for long-term outcomes.
Takayasu arteritis is a rare idiopathic large-vessel vasculitis that typically affects young women. An early prepulseless stage is often missed, associated with nonspecific constitutional symptoms (fever, malaise, and weight loss) and elevated inflammatory markers. Unchecked disease progression leads to the pulseless stage, manifest clinically by missing pulses, vascular tenderness, and ischemic symptoms (limb claudication, dizziness, angina, and renovascular hypertension), and is characterized pathologically by arterial wall thickening and stenotic/occlusive lesions or aneurysm formation. Vascular complications (stroke, blindness, heart failure, and aneurysm rupture) could follow unless disease progression is halted by immunosuppressive therapy and critical lesions are palliated by timely endovascular therapy or open surgery. Early diagnosis, effective therapy, and lifelong surveillance for disease activity relapses and vascular disease progression are critical to successful long-term outcomes. The outlook for patients has improved significantly in recent years with the establishment of diagnostic and classification criteria, better investigational modalities, and more effective medical and invasive therapy. (J Am Coll Cardiol 2023;81:172-186) (c) 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available